Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Acyclovir for Prevention of Eczema Herpeticum in Pediatric Burns
NCT06380647Completed
- Sponsor
- King Edward Medical University
- Start
- Oct 2019
- Primary completion
- Sep 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial in eczema herpeticum (EH) comparing Acyclovir with Placebo (2 arms). Primary endpoint: Number of participants with positive Tzanck smear at 1 year. Started Oct 2019; status: completed.
02
Drugs
aciclovir
03
Conditions
eczema herpeticum (EH)
Beyond the preview
Go deeper on NCT06380647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06380647.